Stress, kisspeptin, and functional hypothalamic amenorrhea

Area of Science:

• Neuroendocrinology
• Reproductive Medicine
• Women's Health

Background:

• Functional hypothalamic amenorrhea (FHA) is the leading cause of secondary amenorrhea in reproductive-aged women.
• FHA results from physical, psychological, or metabolic stressors disrupting the hypothalamic-pituitary-ovarian (HPO) axis.
• Chronic hypoestrogenism in FHA is linked to infertility, sexual dysfunction, osteoporosis, and increased risk of neurodegenerative and cardiovascular diseases.

Purpose of the Study:

• To explore the role of neurotransmitters, particularly kisspeptin, in regulating the HPO axis in FHA.
• To investigate the neural mechanisms underlying FHA and identify potential therapeutic targets.
• To highlight the significance of kisspeptin in the context of FHA and its associated health concerns.

Main Methods:

• Review of existing literature on the neurobiology of FHA.
• Analysis of the involvement of key neurotransmitters like kisspeptin and corticotropin-releasing hormone (CRH) in HPO axis regulation.
• Examination of the consequences of chronic hypoestrogenism in FHA patients.

Main Results:

• Stressors disrupt pulsatile gonadotropin-releasing hormone (GnRH) release, impairing HPO axis function.
• Kisspeptin is a critical neurotransmitter in controlling GnRH secretion and HPO axis activity.
• CRH acts as an intermediary between stress and the reproductive system, inhibiting GnRH pulsatility.

Conclusions:

• Kisspeptin plays a pivotal role in the neural regulation of reproductive function and is implicated in FHA.
• Developing treatments targeting the kisspeptin system, such as kisspeptin receptor agonists, may offer new therapeutic avenues for FHA.
• Further research into the complex neural mechanisms of FHA can lead to improved management strategies for affected women.